Condition: Colon Cancer · Frailty · Sponsor: Copenhagen University Hospital at Herlev
The purpose of the study is to investigate whether an extended program (ERAS 3.0) initiated hospital discharge, can improve recovery in elderly, frail patients who have undergone surgery for colon cancer. The study is a randomised controlled trial with two groups: an intervention group receiving the ERAS 3.0 program and a control group recieving standard care. The ERAS 3.0 program includes a comprehensive geriatric health assessment, dietary counseling from a dietitian, and instructions on training and physical activity. These activities will take place in the participant's homes after hospital discharge. Data will be collected at multiple time points: at the hospital, 12 days post-discharge (at the outpatient clinic), and at 1 and 3 months post discharge in the participants' homes.
This description comes directly from the study's public registry record.
Elna A. Dalsgaard, ph.d. student · +45 42402296 · elna.adalsteinsdottir.dalsgaard@regionh.dk
Jacob Rosenberg, Professor, dr.med. · jacob.rosenberg@regionh.dk
Always discuss trial participation with your own doctor first.
| University Hospital Herlev | Herlev, Denmark | Not Yet Recruiting |
| University Hospital Herlev | Herlev, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06802991